Anika Therapeutics | ANIK - Current Liabilities

Stock Price
14.57
Daily Change
0.29 2.03%
Monthly
13.92%
Yearly
-3.89%
Q1 Forecast
13.43

Anika Therapeutics reported $21.91M in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Abbott USD 16.5B 1.91B Dec/2025
Agenus USD 323.49M 36.36M Dec/2025
Agios Pharmaceuticals USD 82.21M 7.45M Dec/2025
Anika Therapeutics USD 21.91M 2.82M Dec/2025
Arrowhead Research USD 347.42M 151.94M Dec/2025
Enanta Pharmaceuticals USD 44.73M 3.83M Dec/2025
Halozyme Therapeutics USD 177.09M 660.14M Dec/2025
Heron Therapeutics USD 96.1M 6.39M Dec/2025
Insmed USD 468.87M 51.66M Dec/2025
Integra LifeSciences USD 455.98M 91.93M Dec/2025
Intrexon USD 23.02M 38K Jun/2024
J&J USD 54.13B 3.26B Dec/2025
Karyopharm Therapeutics USD 87.16M 12.06M Sep/2025
Ligand Pharmaceuticals USD 37.45M 6.91M Dec/2025
MacroGenics USD 43.11M 1.36M Dec/2025
Merit Medical Systems USD 239.76M 9.29M Dec/2025
Rigel Pharmaceuticals USD 94.4M 7.76M Sep/2025
Sangamo BioSciences USD 47.66M 1.9M Jun/2025
Sanofi EUR 28.35B 3.76B Dec/2025
Smith & Nephew USD 1.54B 236M Dec/2025
Stryker USD 7.79B 380M Dec/2025
Surmodics USD 20.54M 347K Sep/2024
Veracyte USD 59.94M 12.22M Dec/2025
Xencor USD 95.91M 9.42M Dec/2025
Zimmer Biomet Holdings USD 2.58B 180.8M Dec/2025